Delix Therapeutics
company
3 mentions
1 recordings
first heard Apr 2025
last heard Apr 2025
↓3 vs the 12 months before
For‑profit biotech developing non‑hallucinogenic psychedelics
Trend
No mentions in the last 12M.Widen the range to see when Delix Therapeutics was said.
Moments
newest first · ▶ plays the momentRachel CarlsonShort Wave · Could Psychedelics Become Tripless? · 8:13 · Apr 2025
…They help those trees in our brain grow new leaves, but they don't make people hallucinate. Okay, so do we know if these like non-hallucinogenic drugs work? It's definitely still up for debate, but Delix has a drug called DLX-1. It's in clinical trials now. I talked to the company's head of research and development, Eliseo Salinas.…
Rachel CarlsonShort Wave · Could Psychedelics Become Tripless? · 7:53 · Apr 2025
…Yeah, I mean, testing whether something could potentially make a person hallucinate is really tricky, as I'm sure you can imagine. Researchers know certain receptors in our brains are involved in the hallucinogenic effect of psychedelics and ketamine. So companies like Delix are basically trying to make drugs that are like distant cousins of magic mushrooms…
Rachel CarlsonShort Wave · Could Psychedelics Become Tripless? · 1:38 · Apr 2025
…For example, most practitioners would say that people who have bipolar disorder or schizophrenia shouldn't take psychedelics. That's why David's making drugs that are inspired by psychedelics, but without a trip. Wow. OK, so tell me more. So David co-founded a company called Delix Therapeutics. They use the structure of drugs like ketamine, LSD, ibogaine, M…
All 3 moments